The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
2.880
+0.170 (6.27%)
Apr 23, 2025, 4:00 PM EDT - Market closed
The Oncology Institute Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for The Oncology Institute.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for The Oncology Institute.
Recommendation Trends
Rating | Sep '23 | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Jefferies | Jefferies | Strong Buy Initiates $2.5 | Strong Buy | Initiates | $2.5 | -13.19% | Feb 26, 2024 |
Guggenheim | Guggenheim | Strong Buy Maintains $3 → $2 | Strong Buy | Maintains | $3 → $2 | -30.56% | Jun 16, 2023 |
Guggenheim | Guggenheim | Hold Maintains $6 → $3 | Hold | Maintains | $6 → $3 | +4.17% | Mar 20, 2023 |
Guggenheim | Guggenheim | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +108.33% | Nov 11, 2022 |
Jefferies | Jefferies | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +247.22% | Aug 15, 2022 |
Financial Forecast
Revenue This Year
487.63M
from 393.41M
Increased by 23.95%
Revenue Next Year
n/a
from 487.63M
EPS This Year
-0.16
from -0.71
EPS Next Year
n/a
from -0.16
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 |
---|---|
High | 506.9M |
Avg | 487.6M |
Low | 473.1M |
Revenue Growth
Revenue Growth | 2025 |
---|---|
High | 28.9% |
Avg | 23.9% |
Low | 20.3% |
EPS Forecast
EPS | 2025 |
---|---|
High | -0.17 |
Avg | -0.16 |
Low | -0.16 |
EPS Growth
EPS Growth | 2025 |
---|---|
High | - |
Avg | - |
Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.